This transcript has been edited for clarity. Anne Cross, MD: Hello. I am Dr Anne Cross and welcome to Medscape's InDiscussion series on multiple sclerosis (MS). Today we'll be discussing cognitive ...
The Center for Pediatric-Onset Demyelinating Disease (CPODD), directed by pediatric neurologist Dr. Jayne Ness, is one of only six centers in the United States to receive designation as a Pediatric ...
Mayo Clinic and Acorda Therapeutics, Inc. (Nasdaq: ) today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the ...
It's a disease hidden in plain sight. Multiple Sclerosis (MS) impacts about 1 in every 400 people, according to the Multiple Sclerosis Clinic at Riverside Regional Medical Center. That means about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback